The U.S. Food and Drug Administration is suing New York-based Mira Health Products Ltd. and two officials to prevent them from manufacturing and distributing diet supplements that the federal agency claims are “adulterated” due to improper quality control.
The FDA asked the U.S. District Court for the Eastern District of New York for a permanent injunction against the company; Michael Ragno, Mira’s owner and chief operating officer; and Michael Ragno, Jr., Mira’s quality control manager, citing violations of the Federal Food, Drug and Cosmetic Act (FFDCA), according to the complaint.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
